DELOITTE CASE STUDY – RxAll IS USING DL TO FIGHT FAKE MEDICINES AROUND THE WORLD
0 Comments
In its recent report on Intelligent drug supply chain
Creating value from AI, Delloite feature startups around the world creating immense value in the drug supply chain around the world
Case Study 5on page 15 of this report documents our work at RxAll in the fight against counterfeit drugs across the world. Here is what Deloitte has to say below
"RxAll, a US-based start-up, has developed an AI-based technology to assure that patients across the
world have access to authentic, high-quality drugs. Their platform combines a proprietary molecular
sensor (a spectrometer) and a cloud-based DL algorithm, which uses a database of spectral
signatures of drugs, to perform non-destructive verification of drugs authenticity.
Their newest device, the RxScanner II, can identify the authenticity and quality of prescription
drugs – in tablet, powder or liquid forms – in 20 seconds and with an accuracy of 99.9 per cent.
A customised database of drug spectral signatures is built on the RxScanner platform and
real-time information about drug quality and locations of where brand counterfeiting is taking
place can be seen. This technology can be used by different stakeholders, including hospitals,
pharmaceutical companies, pharmacies and regulatory bodies around the world. Their AI system
continuously learns from the spectral reads and can rapidly inform pharmaceutical manufacturers
about counterfeiting.
In 2017, RxAll was selected to participate within the Merck Accelerator Program in Nairobi,
Kenya, and, in 2018, was selected to join the Norwegian Katapult Accelerator to help expand
their operations.
They are currently operating in Canada, China, Ethiopia, Gambia, Ghana,
Kenya, Myanmar, Nigeria, Uganda and the US, and plan to expand in Africa, the Americas and
Southeast Asia.
More recently, RxAll started working with a leading global pharma company with sales operations
across 120 countries to enable faster identification of brand counterfeits across problematic spots
around the world. RxAll developed a spectral library for the client for a significant brand and the
RxScanner was deployed with the client’s drug security team to quickly test suspect brand copies in
trouble spots. Importantly, they allowed test results to be connected in real-time to the drug security
control centres in the US and the UK.
Over a six-month period, RxScanner’s deployment and realtime test reporting to the two control centres reduced reaction time for removing counterfeit copies
of this brand off the market from six weeks to two weeks. RxAll is now expanding the library to
include more brands facing serious counterfeiting problems"
RxDelivered uses cookies to monitor the performance of this website and improve user experience.
To find out more about cookies, please see our privacy policy. Read MoreAccept Cookies
Comments